feed,title,long_url,short_url
SeekingAlpha,FDA places clinical hold on BioMarin's Phase 1/2 gene therapy study in phenylketonuria,https://seekingalpha.com/news/3737387,
SeekingAlpha,Tracking David Einhorn's Portfolio - Q2 2021 Update,https://seekingalpha.com/article/4453804,
